<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04694547</url>
  </required_header>
  <id_info>
    <org_study_id>Ketogenic diet survey in GSDV</org_study_id>
    <nct_id>NCT04694547</nct_id>
  </id_info>
  <brief_title>Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)</brief_title>
  <official_title>Ketogenic Diet Survey in GSDV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nicoline Løkken</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this survey is to report experiences with variants of a ketogenic diet in a&#xD;
      group of individuals diagnosed with McArdle disease (glycogen storage disease type V).&#xD;
      Further more the survey will report on physical activity, fatigue, sleep and quality of life&#xD;
      in this cohort.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, there is no satisfactory treatment for McArdle disease. The limitation in people&#xD;
      with McArdle disease is due to a limited availability of energy in the muscle due to affected&#xD;
      carbohydrate metabolism. A key element in improving muscle function is therefore to introduce&#xD;
      alternative energy sources. Ketone bodies are a well-known source of energy for both brain&#xD;
      and muscle. Ketone bodies are produced during fasting or when following a ketogenic diet. A&#xD;
      ketogenic diet is a diet high in fat and low in carbohydrates. The classic ketogenic diet&#xD;
      contains up to 90% fat, but there are several alternative diets with less fat, including a&#xD;
      modified ketogenic diet, Atkins diet, LCHF (low carb high fat), OMAD (one meal a day) and&#xD;
      more. This survey will collect information on all variations. The rationale for a ketogenic&#xD;
      diet for persons with McArdle disease makes good sense in theory, as the diet would&#xD;
      contribute with a new source of energy (ketone bodies) independent of the affected&#xD;
      carbohydrate breakdown. However, evidence is sparse on whether the diet actually works. The&#xD;
      primary purpose of this survey is to report experiences with variants of the ketogenic diet&#xD;
      in a group of individuals diagnosed with McArdle disease. Secondarily this survey will&#xD;
      collect information on physical activity, fatigue, sleep and quality of life in this cohort&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 10, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Questions on experiences with a ketogenic diet</measure>
    <time_frame>Baseline</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IPAQ (INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE) short form</measure>
    <time_frame>Baseline</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MFI-20 (MULTIDIMENSIONAL FATIGUE INVENTORY)</measure>
    <time_frame>Baseline</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ISI (insomnia severity index)</measure>
    <time_frame>Baseline</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MGQOL 15 score (Myasthenia Gravis Quality Of Life)</measure>
    <time_frame>Baseline</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>McArdle Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>There is no intervention, as this is a survey study</intervention_name>
    <description>Survey</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        McArdle disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Verified GSDV diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicoline Løkken</last_name>
    <phone>+4535458748</phone>
    <email>nicoline.loekken@regionh.dk</email>
  </overall_contact>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>January 4, 2021</last_update_submitted>
  <last_update_submitted_qc>January 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Nicoline Løkken</investigator_full_name>
    <investigator_title>Principal Investigator, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycogen Storage Disease Type V</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

